XM does not provide services to residents of the United States of America.
P
P

Publicis

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Trump, US exposure to sustain Publicis' sector outperformance, Midcap says

BUZZ-Trump, US exposure to sustain Publicis' sector outperformance, Midcap says ** Midcap Partners expects ad agency Publicis PUBP.PA to continue outperforming peers in 2025, with a positive catalyst for consumer sentiment in the U.S. from Donald Trump's election as president. ** Though the new president's economic policy is inflationary, implying higher tariffs, immigration policies, and tax cuts, the broker expects U.S.
P

Publicis Q3 Net Revenue At EUR 3.42 Bln, Up +5.8% Organically

BRIEF-Publicis Q3 Net Revenue At EUR 3.42 Bln, Up +5.8% Organically Oct 17 (Reuters) - Publicis Groupe SA PUBP.PA : Q3 NET REVENUE EUR 3.42 BILLION, +5.8% ORGANIC GROWTH UPS FY 2024 ORGANIC GROWTH GUIDANCE FLOOR TO +5.5% VERSUS +5.0% PREVIOUSLY CONFIRMS 2024 OPERATING MARGIN RATE AT 18.0%, FCF OF BETWEEN EUR 1.8 BILLION AND EUR 1.9 BILLION END-SEPT
P

Ad group Publicis raises revenue forecast again as targeted ads fuel growth

Ad group Publicis raises revenue forecast again as targeted ads fuel growth By Leo Marchandon and Gianluca Lo Nostro Oct 17 (Reuters) - French advertising group Publicis PUBP.PA on Thursday raised its revenue forecast for the second time this year after posting better than expected organic growth in the third quarter, driven by strong client demand for personalized ads .
P

Top of the Street: National Grid, Nestle, K+S, Publicis

BUZZ-Top of the Street: National Grid, Nestle, K+S, Publicis A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Citigroup cuts British energy infrastructure operator National Grid NG.L to "neutral" from "buy" and says the valuation now fairly reflects its growth prospects and policy support after an around 20% re-rating in the last four months ** Citi also downgrades Nestle NESN.S to "neutral" from "buy", saying the short-term earnings downside risk is too
K
N
P
N

AstraZeneca, Danske Bank, Johnson Matthey

EUROPE RESEARCH ROUNDUP-AstraZeneca, Danske Bank, Johnson Matthey Oct 3 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including AstraZeneca, Danske Bank and Johnson Matthey, on Thursday. HIGHLIGHTS * AstraZeneca AZN.L : Jefferies cuts target price to 11,400p from 11,700p * Baltic Classifieds Group Plc BCG.L : Berenberg raises target price to 360p from 300p * Danske Bank DANSKE.CO : JP Morgan cuts target price to DKK 185 from DKK 190 * John
A
B
D
G
K
N
P
P
R
R
S
S
T
V
V
J
N
P

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.